EUVIMEDEUVIMED entdecken
Crossref

Glutathione-specific gamma–glutamylcyclotransferase 1 ( CHAC1 ) increases kidney disease risk by modulating ferroptosis

Lakshmi P Kolligundla iD, Katie M Sullivan iD, Dhanunjay Mukhi iD, Magaiver Andrade-Silva iD, Hongbo Liu iD, Yuting Guan iD, Xiangchen Gu iD, Junnan Wu, Tomohito Doke iD, Daigoro Hirohama iD, Paolo Guarnieri, Jon Hill iD und 4 weitere

Science Translational Medicine · 23.04.2025 · 17 (795)

DOI: 10.1126/scitranslmed.adn3079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 23.04.2025. Verfasst von Lakshmi P Kolligundla und 15 weiteren Autor:innen. Beteiligte Einrichtung: Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 1901…. Hauptthemen laut MEDLINE: gamma-Glutamylcyclotransferase, Ferroptosis, Kidney Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome-wide association studies (GWASs) have identified more than 1000 loci where genetic variants correlate with kidney function. However, the specific genes, cell types, and mechanisms influenced by these genetic variants remain largely uncharted. Here, we identified glutathione-specific gamma–glutamylcyclotransferase 1 ( CHAC1 ) on chromosome 15 as affected by GWAS variants by analyzing human kidney gene expression and methylation information. Both CHAC1 RNA and protein were expressed in the loop of Henle region in mouse and human kidneys, and CHAC1 expression was higher in patients carrying disease risk variants. Using CRISPR technology, we created mice with a single functional copy of the Chac1 gene ( Chac1 +/− ) that displayed no baseline phenotypic alterations in kidney structure or function. These mice demonstrated resilience to kidney disease in multiple models, including folic acid–induced nephropathy, adenine-induced chronic kidney disease, and uninephrectomy-streptozotocin–induced diabetic nephropathy. We further showed that CHAC1 plays a critical role in degrading the cellular antioxidant glutathione. Tubule cells isolated from Chac1 +/− mice showed increased glutathione, decreased lipid peroxidation, improved cell viability, and protection against ferroptosis. Expression of ferroptosis-associated genes was also lower in mice with only one copy of Chac1 . Higher CHAC1 protein also correlated with ferroptosis-related protein abundance in kidney biopsies from patients with kidney disease. This study positions CHAC1 as an important mediator of kidney disease that influences glutathione concentrations and ferroptosis, suggesting potential avenues to explore for the treatment of kidney diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

gamma-GlutamylcyclotransferaseFerroptosisKidney DiseasesAnimalsHumansGlutathioneMiceGenome-Wide Association StudyRisk FactorsKidneyMale

Substanzen

gamma-GlutamylcyclotransferaseGlutathione

Autor:innen und Institutionen

  • Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19014, USA.
  • Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19014, USA.
  • Penn/CHOP Kidney Innovation Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19014, USA.
  • Department of Pediatrics, Medical College of Wisconsin Pediatric Nephrology, Milwaukee, WI 53226, USA.
  • Department of Cardiometabolic Diseases Research, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT 06877, USA.
  • ONO Pharmaceuticals Inc., Cambridge, MA 02142, USA.

ORCID-Profile: Lakshmi P Kolligundla, Katie M Sullivan, Dhanunjay Mukhi, Magaiver Andrade-Silva, Hongbo Liu, Yuting Guan, Xiangchen Gu, Tomohito Doke, Daigoro Hirohama, Jon Hill, Steven S Pullen, Jay Kuo, Masataka Inamoto, Katalin Susztak

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Kolligundla, L. P., Sullivan, K. M., Mukhi, D., Andrade-Silva, M., Liu, H., Guan, Y., Gu, X., Wu, J., Doke, T., Hirohama, D., Guarnieri, P., Hill, J., Pullen, S. S., Kuo, J., Inamoto, M., & Susztak, K. (2025). Glutathione-specific gamma–glutamylcyclotransferase 1 ( CHAC1 ) increases kidney disease risk by modulating ferroptosis. Science Translational Medicine, 17(795). https://doi.org/10.1126/scitranslmed.adn3079

Vancouver

Kolligundla LP, Sullivan KM, Mukhi D, Andrade-Silva M, Liu H, Guan Y, et al. Glutathione-specific gamma–glutamylcyclotransferase 1 ( CHAC1 ) increases kidney disease risk by modulating ferroptosis. Science Translational Medicine. 2025;17(795). doi:10.1126/scitranslmed.adn3079

BibTeX
@article{Kolligundla2025,
  author = {Kolligundla, Lakshmi P and Sullivan, Katie M and Mukhi, Dhanunjay and Andrade-Silva, Magaiver and Liu, Hongbo and Guan, Yuting and Gu, Xiangchen and Wu, Junnan and Doke, Tomohito and Hirohama, Daigoro and Guarnieri, Paolo and Hill, Jon and Pullen, Steven S and Kuo, Jay and Inamoto, Masataka and Susztak, Katalin},
  title = {Glutathione-specific gamma–glutamylcyclotransferase 1 ( CHAC1 ) increases kidney disease risk by modulating ferroptosis},
  journal = {Science Translational Medicine},
  year = {2025},
  volume = {17},
  number = {795},
  doi = {10.1126/scitranslmed.adn3079}
}
Kostenlos starten →